Principal Software Engineering
Demandbase120,000 - 180,000 USD/year
- Full Time
- Expert & Leadership (9+ years), Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug DiscoveryIndustries
Requirements
Candidates should possess a Bachelor's degree in Computer Science or a related field, and have at least 8 years of experience in software engineering, with a strong focus on software architecture and technical leadership. They should be comfortable working across all levels of the software stack, possess mastery of writing production code, and have a proven track record of successfully driving projects to completion. A deep understanding of first principles, a balance between detail and architectural thinking, and an investigational curiosity for problem-solving are essential.
Responsibilities
The Principal Software Engineer will provide technical insights to the head of engineering and head of computational chemistry on software architecture, scale the company’s data infrastructure to handle large datasets and parallel computing jobs, lead, mentor, and coach engineers from diverse backgrounds (chemistry and computer science), and contribute to the development and maintenance of the GEMS (Genesis Exploration of Molecular Space) platform, a molecular AI platform for accelerating drug discovery. They will also play a role in collaborating with pharmaceutical companies and advancing the company’s AI-focused platform collaborations.
Skills
Software Architecture
Machine Learning
Data Infrastructure
APIs
Python
Molecular Dynamics
Quantum Chemistry
Biophysical Simulation
Computational Chemistry
C++
Cloud Computing
Genesis Therapeutics
AI-driven drug discovery for pharmaceuticals
About Genesis Therapeutics
Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.
Key Metrics
Burlingame, CaliforniaHeadquarters
2019Year Founded
$272.5MTotal Funding
SERIES_BCompany Stage
AI & Machine Learning, BiotechnologyIndustries
51-200Employees